Amgen Inc (NASDAQ:AMGN)

156.26
Delayed Data
As of May 29
 -1.09 / -0.69%
Today’s Change
114.93
Today|||52-Week Range
173.60
-1.90%
Year-to-Date

Today’s Trading

Previous close157.35
Today’s open156.79
Day’s range155.58 - 157.97
Volume4,414,342
Average volume (3 months)3,322,698
Market cap$118.8B
Dividend yield2.02%
Data as of 4:00pm ET, 05/29/2015

Growth & Valuation

Earnings growth (last year)+0.90%
Earnings growth (this year)+9.83%
Earnings growth (next 5 years)+10.00%
Revenue growth (last year)+7.30%
P/E ratio21.1
Price/Sales6.03
Price/Book4.61

Competitors

 Today’s
change
Today’s
% change
BIIBBiogen-3.11-0.78%
GILDGilead Sciences-0.58-0.51%
BAXBaxter International...-0.54-0.80%
GEVASynageva BioPharma C...-1.18-0.55%
Data as of 4:14pm ET, 05/29/2015

Financials

Next reporting dateJuly 29, 2015
EPS forecast (this quarter)$2.40
Annual revenue (last year)$20.0B
Annual profit (last year)$5.2B
Net profit margin25.74%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Robert A. Bradway
Executive Vice President-
Operations
Madhu Balachandran
Corporate headquarters
Thousand Oaks, California

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers